A Phase 3, Multicenter, Double-blind Maintenance Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Subjects With Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-ASCEND)

Project: Research

Project Details

Project Description

Animal Ethics: Not required; Human Ethics: N/A (Ethics remains through Alfred as per head agreement); Gene Tech: Not required; Biosafety/Radiation: No; Split Grants: N/A
StatusActive
Effective start/end date1/09/23 → 31/08/25

Keywords

  • Clinical trial
  • 20210146
  • ROCKET-ASCEND